verified SJR 1,326 · Q1 • database Scopus / SJR & Web of Science indexed

United Kingdom · Elsevier Ltd

workspace_premium Q1 — Oncology lock_open Open Access Unclaimed

Oral Oncology

Oral Oncology is a journal indexed in SJR in Oncology and Cancer Research with an H index of 143. It has an SJR impact factor of 1,326 and it has a best quartile of Q1. It is published in English. It has an SJR impact factor of 1,326.

Oral Oncology focuses its scope in these topics and keywords: squamous, cell, head, carcinoma, neck, receptor, surgical, cancer, therapeutic, cells, ...

ISSN: 1368-8375

Editorial: Elsevier Ltd

Category: Oncology

Indexation: verifiedScopus / SJR verifiedWeb of Science

Unclaimed profile — some fields may be incomplete.

open_in_new Portal NPD menu_book Guidelines NPD

schedule Datos CoP · solo campos en BD

SJR Impact Factor trending_up

1,326 Q1

H-index 143

Tasa de Aceptación pie_chart

23% Selectiva

Fuente Acceptance_Rate

Tiempo a publicación hourglass_top

NPD

Campo Sin dato

Coste de Publicación (APC) payments

NPD Open Access

Ruta Non-OA 0 €

Metrics

Campos Scimago / CoP — sin series inventadas

Scopus / SJR Web of Science

SJR Impact

1,326

H-index

143

Docs (year)

394

Docs 3y

1146

Total refs

9483

Cites 3y

2879

Citable 3y

535

Cites/Doc 2y

2.29

Ref/Doc

24.07

Immediate OA

—

Embargoed OA

NPD

Non OA / Submission

0 €

shield Researcher voice

Name good journals. Call out predatory ones.

Share what peer review, fees, and timelines were really like. Praise fair editors. Flag APC traps, fake metrics, or spam solicitations — with facts from your submission.

Fair & fast peer review Clear APC / no surprise fees Suspected predatory Fake impact claims

rate_review Write an honest review

Researcher reviews

sentiment_dissatisfied No reviews yet — be the first to share an honest experience.

Publication speed *

Review quality *

Edition and editorial team *

Institutional email or ORCID * * Only to validate authenticity — identity is not shown publicly.

Best articles by citations

Cellular neurothekeoma of the oral mucosa

Verruciform xanthoma of the oral mucosa: An immunohistochemical and ultrastructural study of two cases

Effect of N-CAM on in vitro invasion of human adenoid cystic carcinoma cells

Distinct patient groups in oral cancer: a prospective study of perceived health status following primary surgery

Diagnosis of oral cancer by light-induced autofluorescence spectroscopy using double excitation wavelengths

Detection of oral and oropharyngeal cancer by microsatellite analysis in mouth washes and lesion brushings

Dental factors in the genesis of squamous cell carcinoma of the oral cavity

Cytotoxic effect of pingyangmycin on cultured KB cells

Correlation between p53 mutation and cyclin D1 amplification in head and neck squamous cell carcinoma

Correlation between p53 gene mutations and circulating antibodies in betel- and tobacco-consuming North Indian population

Congenital malignant rhabdoid tumour of the gum margin

Comparisons of norcantharidin cytotoxic effects on oral cancer cells and normal buccal keratinocytes

SHOW MORE ARTICLES

Cisplatin inhibits the expression of X-chromosome-linked inhibitor of apoptosis protein in an oral carcinoma cell line

5-Fluorouracil-induced apoptosis in cultured oral cancer cells

Carcinoma of the hard palate treated with radiotherapy: a retrospective review of 31 cases

Benign fibrous histiocytoma (BHF) of the cheek: CD 68-KP1 positivity

Basaloid squamous cell carcinoma versus basal cell ameloblastoma

Atypical mitoses in lesions of the oral mucosa: a new interpretation of their impact upon tumorigenesis

Assessment of proliferating cell nuclear antigen in nasopharyngeal carcinoma tissue and its relation to clinical findings

Apoptosis, mitosis, PCNA and bcl-2 in normal, leukoplakic and malignant epithelia of the human oral cavity: Prospective, in vivo study

Angiomyolipoma of the palate. Report of a case

Amitotic cell divisions and tumour growth: an alternative model for cell kinetic compartments in solid tumours

Allelic imbalance at chromosomal loci implicated in the pathogenesis of oral precancer, cumulative loss and its relationship with progression to cancer

A conjugate of doxorubicin and an analog of Luteinizing Hormone-Releasing Hormone shows increased efficacy against oral and laryngeal cancers

FAQS

In Country of Papers you can find SJR impact factor and other metrics to help you decide on a Journal.